Novartis International AG (NVS) Says Glivec Has Potential to Treat PAH; Drug Did Not Reach Statistical Significance In Main Target  
10/8/2008 7:48:50 AM

ZURICH, Oct 8 (Reuters) - Novartis AG's cancer drug Glivec had the potential to treat a rare heart and lung condition in a mid-stage trial, but did not reach its main target in the study.